FENOFIBRATE

Product NDC: 33261-966
11-digit product format: 332610966
Labeler code: 33261
Product ID: 33261-966_7cab8cc1-8128-45fc-87a2-639f07d4d60f
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: FENOFIBRATE
Dosage form: TABLET
Route: ORAL
Labeler: Aidarex Pharmaceuticals LLC
Application: ANDA076509
Marketing category: ANDA
Marketing start: 2010-02-01
Marketing end: 0000-00-00
Substance: FENOFIBRATE
Active strength: 54 mg/1
Pharmacologic classes: Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC]
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	33261-966		I	Inactivated by FDA		2026-08-10
excluded package	package	33261-966	33261-966-30	I	Inactivated by FDA		2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	33261-966-30	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	33261-966-30	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	33261-966-30	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	33261-966-30	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	33261-966-30	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	33261-966-30	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	33261-966-30	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	33261-966-30	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	33261-966-30	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	33261-966-30	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	33261-966-30	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	33261-966-30	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	33261-966-30	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	33261-966-30	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	33261-966-30	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	33261-966-30	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	33261-966-30	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	33261-966-30	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	33261-966-30	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	33261-966-30	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	33261-966-30	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	33261-966-30	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A076509-001	FENOFIBRATE	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26
A076509-002	FENOFIBRATE	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A076509-001	AB
A076509-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A076509-001	FENOFIBRATE	54MG	TABLET / ORAL	AB		2008-03-26	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A076509-002	FENOFIBRATE	160MG	TABLET / ORAL	AB	RS	2008-03-26	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076509-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076509-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076509-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076509-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076509-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076509-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076509-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076509-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076509-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076509-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076509-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076509-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076509-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076509-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076509-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076509-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076509-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076509-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076509-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076509-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076509-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076509-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076509-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076509-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076509-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076509-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076509-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A076509-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076509-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076509-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A076509-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A076509-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A076509-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A076509-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A076509-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076509-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A076509-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A076509-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A076509-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A076509-002	AB	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
193bb7da-5c03-8f95-9048-23ef403846b0	Product name	3	20250616
fa35fb9a-7146-716b-13c8-bc1f60030232	Product name	9	20250114
cfc78bfa-7d55-47e5-aeb7-71cd79f5ca07	Product name	8	20231212
ed9d55d4-85bd-0ee7-5b4a-b705646a3a66	Product name	9	20200708
36a239c8-03fb-0083-81af-6c1afb195671	Product name	1	20140508
a0296d70-ca85-018c-84e8-cf3f630976b7	Product name	1	20140508
f2e3e9c8-a2f9-0cc3-a5a5-6dfd0279372a	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
33261-966-30	2020-01-31	C162847	48780-1	9d75b9d0-a294-f424-e053-dadaa90a57ce	FENOFIBRATE TABLETS, 54 mg and 160 mg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
33261-966-30	FENOFIBRATE	30 in 1 BOTTLE, PLASTIC	TABLET	30		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
33261-966-30	EA - Each	33261-966	fdc0b615-8496-4f64-9798-8700dd8a63c3	1	2015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
FENOFIBRATE	ACTIVE INGREDIENT	U202363UOS	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1
FENOFIBRATE	ACTIVE MOIETY	U202363UOS	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1
HYPROMELLOSE 2910 (3 MPA.S)	INACTIVE INGREDIENT	0VUT3PMY82	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1
HYPROMELLOSE 2910 (50 MPA.S)	INACTIVE INGREDIENT	1IVH67816N	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1
POLYDEXTROSE	INACTIVE INGREDIENT	VH2XOU12IE	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
33261-966	FENOFIBRATE TABLET [AIDAREX PHARMACEUTICALS LLC]	1	Legacy NDC, 1 package rows	20140107_b4ae2a4c-68f7-468e-9951-4dd11dd8c33d.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
FENOFIBRATE	FENOFIBRATE	Amneal Pharmaceuticals LLC	65f5dcad-5073-4347-9ec9-e7f350b134c4	2026-06-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509
FENOFIBRATE	FENOFIBRATE	Northwind Health Company, LLC	4b4447a1-8136-4258-b2c8-c5f9c1bcec92	2025-12-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509
FENOFIBRATE	FENOFIBRATE	AvPAK	d4e1d692-3c03-7406-ee06-7a6fb39ed3e7	2025-11-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509
FENOFIBRATE	FENOFIBRATE	REMEDYREPACK INC.	882ee82a-3c56-4173-af42-68c3aadc8aa7	2025-10-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509
FENOFIBRATE	FENOFIBRATE	PD-Rx Pharmaceuticals, Inc.	35ba17d9-0dd7-4f15-8f74-be5fd15f1917	2025-04-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509
FENOFIBRATE	FENOFIBRATE	A-S Medication Solutions	3f2b3a16-7735-487e-9a2c-e078a18df1bc	2024-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509
FENOFIBRATE	FENOFIBRATE	A-S Medication Solutions	f937a176-3d3e-4dc6-a7d4-c1a4749c7a7f	2023-12-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509
FENOFIBRATE	FENOFIBRATE	Amneal Pharmaceuticals of New York LLC	fa08cf6a-d306-4979-9b23-ac7febf4fd12	2021-04-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076509 application number: ANDA076509

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
U202363UOS	FENOFIBRATE	49562-28-9	FENOFIBRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
351133	fenofibrate 54 MG Oral Tablet	PSN	b4ae2a4c-68f7-468e-9951-4dd11dd8c33d	1
351133	fenofibrate 54 MG Oral Tablet	SCD	b4ae2a4c-68f7-468e-9951-4dd11dd8c33d	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
33261-966-30	33261096630	30 in 1 BOTTLE, PLASTIC	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
FENOFIBRATE TABLETS, 54 mg and 160 mg	Aidarex Pharmaceuticals LLC	2014-01-01	HUMAN PRESCRIPTION DRUG LABEL	1